Kintor Pharma prices IPO high to net $240m

Jonathan Breen

May 18, 2020 07:30 AM

pills adobe stock 575x375 pharmaceuticals — Heap of medical pills in white, blue and other colors. Pills in plastic package. Panoramic banner for design. | OKSANA KAZYKINA/okskaz - stock.adobe.com

Kintor Pharmaceutical has notched another success for the healthcare sector, raising HK$1.86bn ($240m) from its IPO after pricing the deal at the top of the marketed range.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOs UBS Equity China Merchants Bank Co China China International Capital Corp China Everbright Bank Co Hong Kong SAR Asia Coronavirus Greater China Haitong Securities Northeast Asia Asia Pacific Emerging Markets Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia